Menu
GeneBe

PRDM5

PR/SET domain 5, the group of Zinc fingers C2H2-type|PR/SET domain family

Basic information

Region (hg38): 4:120684918-120922870

Links

ENSG00000138738NCBI:11107OMIM:614161HGNC:9349Uniprot:Q9NQX1AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • brittle cornea syndrome 2 (Strong), mode of inheritance: AR
  • brittle cornea syndrome 2 (Strong), mode of inheritance: AR
  • brittle cornea syndrome 2 (Moderate), mode of inheritance: AR
  • brittle cornea syndrome (Supportive), mode of inheritance: AR
  • brittle cornea syndrome 2 (Definitive), mode of inheritance: AR
  • brittle cornea syndrome 2 (Strong), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Brittle cornea syndrome 2AROphthalmologicIndividuals are prone to ophthalmologic injury (such as corneal rupture) with minimal trauma, and protective measures may be beneficialAudiologic/Otolaryngologic; Cardiovascular; Craniofacial; Musculoskeletal; Ophthalmologic21664999; 22122778; 26395458
Manifestations can occur in heterozygote

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the PRDM5 gene.

  • not provided (271 variants)
  • Cardiovascular phenotype (182 variants)
  • Brittle cornea syndrome 2 (37 variants)
  • Ehlers-Danlos syndrome (30 variants)
  • Brittle cornea syndrome 1 (29 variants)
  • not specified (25 variants)
  • Inborn genetic diseases (12 variants)
  • Connective tissue disorder (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the PRDM5 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
2
clinvar
87
clinvar
4
clinvar
93
missense
1
clinvar
141
clinvar
9
clinvar
2
clinvar
153
nonsense
7
clinvar
3
clinvar
2
clinvar
12
start loss
1
clinvar
1
frameshift
3
clinvar
5
clinvar
8
inframe indel
0
splice donor/acceptor (+/-2bp)
8
clinvar
8
splice region
7
5
2
14
non coding
14
clinvar
69
clinvar
40
clinvar
123
Total 10 17 158 167 46

Highest pathogenic variant AF is 0.00000658

Variants in PRDM5

This is a list of pathogenic ClinVar variants found in the PRDM5 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
4-120694935-A-G Brittle cornea syndrome 1 Uncertain significance (Jun 14, 2016)347426
4-120694957-T-A Brittle cornea syndrome 1 Uncertain significance (Jun 14, 2016)347427
4-120694970-A-G Brittle cornea syndrome 1 Uncertain significance (Jun 14, 2016)347428
4-120694991-A-G Brittle cornea syndrome 1 Conflicting classifications of pathogenicity (Jun 26, 2018)347429
4-120695107-C-T Likely benign (Jul 19, 2019)1180011
4-120695114-G-A Likely benign (Nov 24, 2022)2816512
4-120695117-G-A Brittle cornea syndrome 1 Uncertain significance (Jun 14, 2016)347430
4-120695130-T-C Cardiovascular phenotype Uncertain significance (Feb 20, 2023)2450364
4-120695132-G-T PRDM5-related disorder Likely benign (Aug 26, 2022)3029831
4-120695142-A-G Cardiovascular phenotype Uncertain significance (Feb 09, 2023)1781532
4-120695145-TG-T Brittle cornea syndrome 2 Likely pathogenic (Aug 01, 2020)981043
4-120695153-G-A Ehlers-Danlos syndrome • Cardiovascular phenotype Conflicting classifications of pathogenicity (Jan 04, 2024)391274
4-120695156-G-A Likely benign (Jul 11, 2023)2973202
4-120695157-T-C Uncertain significance (Jun 14, 2019)1315637
4-120695171-A-G Cardiovascular phenotype Likely benign (Mar 26, 2021)1781006
4-120695195-T-C Cardiovascular phenotype Likely benign (Aug 29, 2023)2626689
4-120695199-G-C Uncertain significance (Jan 03, 2022)2073145
4-120695200-C-T Cardiovascular phenotype Uncertain significance (Sep 16, 2020)1780456
4-120695209-G-A Ehlers-Danlos syndrome • Cardiovascular phenotype Uncertain significance (Nov 29, 2023)1702269
4-120695211-T-C Uncertain significance (Apr 01, 2022)1493818
4-120695213-G-A Cardiovascular phenotype Likely benign (Aug 02, 2023)1780194
4-120695217-TTA-T Brittle cornea syndrome 2 Likely pathogenic (Apr 20, 2022)1683364
4-120695234-T-G Cardiovascular phenotype Likely benign (Sep 21, 2019)1779780
4-120695236-G-A Brittle cornea syndrome 2 Pathogenic (Mar 01, 2020)31111
4-120695246-T-C Likely benign (May 22, 2023)2791474

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
PRDM5protein_codingprotein_codingENST00000264808 16237952
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
3.60e-100.9821257040431257470.000171
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.6983053410.8940.00001804238
Missense in Polyphen112134.480.832821577
Synonymous-1.291361181.150.000006281054
Loss of Function2.322136.10.5820.00000185467

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0004780.000478
Ashkenazi Jewish0.000.00
East Asian0.0002740.000272
Finnish0.000.00
European (Non-Finnish)0.0002030.000202
Middle Eastern0.0002740.000272
South Asian0.00009820.0000980
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Sequence-specific DNA-binding transcription factor. Represses transcription at least in part by recruitment of the histone methyltransferase EHMT2/G9A and histone deacetylases such as HDAC1. Regulates hematopoiesis-associated protein-coding and microRNA (miRNA) genes. May regulate the expression of proteins involved in extracellular matrix development and maintenance, including fibrillar collagens, such as COL4A1 and COL11A1, connective tissue components, such as HAPLN1, and molecules regulating cell migration and adhesion, including EDIL3 and TGFB2. May caused G2/M arrest and apoptosis in cancer cells. {ECO:0000269|PubMed:15077163, ECO:0000269|PubMed:17636019, ECO:0000269|PubMed:21664999}.;

Recessive Scores

pRec
0.0981

Intolerance Scores

loftool
0.411
rvis_EVS
-0.62
rvis_percentile_EVS
17.36

Haploinsufficiency Scores

pHI
0.436
hipred
N
hipred_score
0.492
ghis
0.531

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.967

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Prdm5
Phenotype
skeleton phenotype;

Zebrafish Information Network

Gene name
prdm5
Affected structure
anterior neural plate
Phenotype tag
abnormal
Phenotype quality
decreased length

Gene ontology

Biological process
negative regulation of transcription by RNA polymerase II;mitotic cell cycle;histone deacetylation;negative regulation of transcription, DNA-templated;histone H3-K9 methylation;cellular response to leukemia inhibitory factor
Cellular component
nucleus;nucleolus;nuclear body
Molecular function
RNA polymerase II regulatory region sequence-specific DNA binding;RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription repressor activity, RNA polymerase II-specific;DNA-binding transcription factor activity;protein binding;methyltransferase activity;chromatin DNA binding;sequence-specific DNA binding;transcription regulatory region DNA binding;metal ion binding;repressing transcription factor binding